Being one of the top 10 key players in the generic pharmaceutical industry in the MENA region, coupled with its in-depth experience and expertise in manufacturing and marketing, Axantia is well-placed to be the partner of choice for companies looking to establish business in this part of the world. This is for the following reasons:

• Strong local operational infrastructure & expertise across MENA markets
• Financially strong to allow sufficient funds and securities to cater for our growth
• High investment in infrastructure, product development and human capital
• Continuous growth

We partner with selected pharmaceutical companies to provide access to finished products across the MENA region.

Indian partners
Dr. Reddy’s
MSN
Hetero
European partners
Selectchemie
Welding
Pharmathen
Chanelle
Jordanian partners
Savvy Pharma
Sana Pharma

At Axantia we adhere to applying best practices in the market with compliance as a cornerstone in our behavior. We believe in human capital, home established art and in-house training center for sales and marketing to ensure building capabilities and unique skills that can drive performance.

MD aggressive steps toward building a state of art manufacturing facility that will be fully operational first 3 quarter 2019